CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

Summary

The industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Germany. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis byThes team of industry experts.

Germany is a mature healthcare market, with a strong focus on pharma R&D, production, and government policies supporting higher healthcare expenditure. In 2017, Germany spent $5,728 per capita on healthcare, which was higher than the OECD average of $4,069 per capita. In 2010, Germany had pharmaceutical sales of $39.4B. This increased to $40B in 2016. The market value is expected to reach $40.5B in 2022, growing at a Compounded Annual Growth Rate (CAGR) of 0.25%. The German medical device market was valued at $28B in 2015, which increased to $33.7B in 2020, growing at a CAGR of 3.7%.The increasing elderly population and associated disease burden are expected to drive the growth of the pharmaceutical market. However, the government initiated price-cap agreements to reduce healthcare expenditure have limited growth. The German healthcare system is characterized by universal insurance coverage, good accessibility to healthcare facilities, and adequate healthcare reimbursement. Germany offers more than 30 specialized cluster networks focusing on continuous innovation and R&D.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Merck, Bayer, Pfizer, Boehringer Ingelheim and Novartis) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Fresenius, GE Healthcare, Essilor and B Braun)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Germany
- Porters five forces analysis for pharmaceutical and medical devices market of Germany
- An insightful review of the reimbursement and regulatory landscape, of which analysis include details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in Germany healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Germany healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in Germany healthcare market.

Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porters Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List Of Tables

Table 1: Pharmaceutical Market, Germany, Sales of Patented Drug Products by Major Therapeutic Class ($m), 2016
Table 2: Medical Device Market, Germany, Revenue by Segment ($B), 2018
Table 3: Cardiovascular Devices , Germany, Revenue ($M) and Market Share (%) of Major Companies
Table 4: IVD Market, Germany, Revenue ($M) and Market Share (%) of Major Companies
Table 5: Wound Care Management Market, Germany, Revenue ($M) and Market Share (%) of Major Companies
Table 6: Orthopedic Devices Market, Germany, Revenue ($M) and Market Share (%) of Major Companies
Table 7: Patent Fees, Germany, 2018
Table 8: Trademark Fees, Germany, 2018
Table 9: Requirements of Advertising of Pharmaceutical Products Through Mass Media
Table 10: Label of a Pharmaceutical Product
Table 11: Labeling and Packaging Leaflet

List Of Figures

Figure 1: Pharmaceutical Market, Germany, Revenue ($B), 2010-2017
Figure 2: Medical Device Market, Germany, Revenue ($B), 2015-2020
Figure 3: Number of Deals (2018-2019)
Figure 4: 2018-19 Deal Overview By Region
Figure 5: Country Profile, Germany, 2018
Figure 6: Pharmaceutical Market, Germany, Revenue ($B), 2010-2017
Figure 7: Pharmaceutical Market, Germany, Revenue Forecast ($B), 2018-2022
Figure 8: Pharmaceutical Market, Germany, Pharmaceutical Exports
Figure 9: Pharmaceutical Market, Germany, Top Export Partners
Figure 10: Pharmaceutical Market, Germany, Pharmaceutical Imports
Figure 11: Pharmaceutical Market, Germany, Top Import Partners
Figure 12: Pharmaceutical Market, Germany, Supply Channels
Figure 13: Generics Market, Germany, Revenue ($B), 2010-2016
Figure 14: Pharmaceutical OTC Market, Germany, Revenue ($B), 2010-2017
Figure 15: Major OTC Drug Classes (Share%), Germany, 2017
Figure 16: Government Funded Biosimilars, Germany, 2017
Figure 17: Pharmaceutical Market, Germany, Sales of Patented Drug Products by Major Therapeutic Class ($B), 2016
Figure 18: Pharmaceutical Market, Major Players, Germany
Figure 19: Medical Device Market, Germany, Revenue ($B), 2015-2020
Figure 20: Medical Device Market, Germany, Revenue Forecast ($B), 2021-2025
Figure 21: Medical Device Market, Germany, Revenue by Segment ($B), 2018
Figure 22: Cardiovascular Devices Market, Germany, Revenue ($B), 2015-2022
Figure 23: Cardiovascular Devices Market, Germany, Market Share of Major Players (%)
Figure 24: IVD Market, Germany, Revenue ($B), 2015-2022
Figure 25: IVD Market, Germany, Market Share of Major Players (%)
Figure 26: Wound Care Management Market, Germany, Revenue ($B), 2015-2022
Figure 27: Wound Care Management Market, Germany, Market Share of Major Players (%)
Figure 28: Orthopedic Market, Germany, Revenue ($B), 2015-2022
Figure 29: Orthopedic Devices Market, Germany, Market Share of Major Players (%)
Figure 30: Ophthalmic Devices Market, Germany, Revenue ($B), 2015-2022
Figure 31: Ophthalmic Devices Market, Germany, Market Share of Major Players (%)
Figure 32: Diagnostic Market, Germany, Revenue ($B), 2015-2018
Figure 33:Diagnostic Market, Germany, Revenue Forecast ($B), 2019-2022
Figure 34: Medical Device Market - Major Players
Figure 35: Deal Value and Deal Count, Pharmaceutical Market, Germany, 2018-2019
Figure 36: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Germany, 2018-2019
Figure 37: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Germany, 2018-2019
Figure 38: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Germany, 2018-2019
Figure 39: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, Germany, 2018-2019
Figure 40: M&A Deals by Therapy Area, Pharmaceutical Market, Germany, 2018-2019 (by value and by number)
Figure 41: Venture Financing Deals by Therapy Area, Pharmaceutical Market Germany, 2018-2019 (by value and by number)
Figure 42: Medical Device Market Deals, Germany, 2018-2019(by deal value, $M)
Figure 43: Medical Device Market Deals, Germany, 2018 -2019(by deal count)
Figure 44: Medical Device Market Deals Share (by deal count), Germany, 2018 -2019
Figure 45: Medical Device Market Deals Share (by deal value), Germany, 2018 -2019
Figure 46: Top Five Therapy Areas by Deal Value, Medical Device, Germany, 2018-2019
Figure 47: Top Five Therapy Areas by Deal Number, Medical Device, Germany, 2018-2019
Figure 48: M&A Deals by Therapy Area, Medical Device, Germany, 2018-2019 (by number)
Figure 49: Venture Financing Deals by Therapy Area, Medical Device, Germany, 2018-2019 (by value and by number)
Figure 50: Private Equity Deals by Therapy Area, Medical Device Germany, 2018-2019(By number)
Figure 51: Healthcare System, Germany, 2018
Figure 52: Regulatory Authorities, Reimbursement Process, 2018
Figure 53: Reimbursement Process, Germany, 2018
Figure 54: Number of SHI Providers , Germany, 2010-2018
Figure 55: PKV-Aging Provisions ($B), 2006-2016, Germany
Figure 56: OOP Expenditure (% of total expenditure on health)
Figure 57: Annual Rate of Change (%), Consumer Price Index

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available